Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Clin. biomed. res ; 34(3): 297-306, 2014. graf, ilus
Article in English | LILACS | ID: biblio-834463

ABSTRACT

Introduction: Mouse models of emphysema are important tools for testing different therapeutic strategies. The aim of this study was to develop a mouse model of emphysema induced by different doses of elastase in order to produce different degrees of severity. Methods: Thirty female mice (C57BL/6) were used in this study. Different doses of porcine pancreatic elastase were administered intratracheally once a week for four weeks, as follows: 0.1 U (n=8), 0.15 U (n=7), and 0.2 U (n=7). Control mice (n=8) received 50 microL of sterile saline solution intratracheally. Lung mechanics were analyzed by plethysmography. Mean linear intercept and volume fraction occupied by collagen and elastic fibers were determined. Results: An increase in lung resistance was observed with 0.2 U of elastase [median (P-25-P75): 2.02 (1.67; 2.34) cmH2O.s/mL], as well as a decrease in tidal volume and minute ventilation. Peak expiratory flow increased significantly in the groups treated with 0.15 U and 0.2 U of elastase. Mean linear intercept was higher with 0.15 U and 0.2 U of elastase, with destruction of alveolar walls [median (P-25-P75): 30.31 (26.65-43.13) microm and 49.49 (31.67-57.71) microm respectively]. The volume fraction occupied by collagen and elastic fibers was lower in the group receiving 0.2 U of elastase. Conclusion: Four intratracheal instillations of 0.2 U of elastase once a week induced changes in lung function and histology, producing an experimental model of severe pulmonary emphysema, whereas 0.15 U resulted in only histological changes.


Subject(s)
Animals , Mice , Pancreatic Elastase/administration & dosage , Pancreatic Elastase/toxicity , Pulmonary Emphysema/chemically induced , Pulmonary Emphysema/metabolism
2.
Rio de Janeiro; s.n; 2012. 115 p. ilus, tab.
Thesis in Portuguese | LILACS | ID: lil-663605

ABSTRACT

Este estudo buscou investigar o papel do estresse oxidativo e nitrosativo no enfisema pulmonar induzido por elastase. Foram utilizados camundongos machos C57BL/6 submetidos a dois modelos de indução do enfisema por elastase pancreática suína (PPE): intratraqueal (i.t.) e intranasal (i.n.). No modelo intratraqueal a PPE foi instilada nas doses de 0,05 U ou 0,05 U/camundongo para avaliação temporal do enfisema 7, 14 e 21 dias após instilação de PPE. Em outra etapa, o papel da iNOS foi avaliado através da sua inibição farmacológica por aminoguanidina (AMG) 1% na água de beber ou pela sua exclusão genética em camundongos deficientes em iNOS que tiveram o enfisema induzido por 0,5 U PPE i.t. após 21 dias. No modelo intranasal a dose de PPE foi 3 U/camundongo para avaliação temporal do enfisema (1, 7, 14 e 21 dias após PPE). O papel do estresse oxidativo e nitrosativo foi avaliado com diferentes tratamentos antioxidantes na água de beber: tempol, apocinina+alopurinol, n-acetilcisteína, vitamina C+E, e aminoguanidina durante os 21 dias de indução do enfisema. Os grupos controles foram submetidos à instilação de salina. Lavado broncoalveolar, imunoensaios, análises bioquímicas de estresse oxidativo e ensaios morfométricos foram realizados nos pulmões dos animais. O enfisema foi histologicamente alcançado em 21 dias após 0,5 U PPE i.t., evidenciado pelo aumento do diâmetro alveolar médio - Lm e da densidade de volume dos espaços alveolares - Vvair em comparação ao grupo controle. TNF-a foi aumentado em 7 e 14 dias após 0,05 U PPE comparados ao controle, concomitante com a redução de IL-10 nos mesmos períodos, comparados ao controle. O estresse oxidativo foi observado na fase inicial do enfisema, com aumento dos níveis de nitrito, TBARS e superóxido dismutase no grupo 7 dias após 0,5 U PPE (i.t.) quando comparados ao controle ao passo que no modelo intranasal as alterações típicas do estresse foram vistas no grupo 1 dia após 3 U de PPE. Atividade da glutationa ...


This study investigated the role of oxidative and nitrosative stress in elastase-induced pulmonary emphysema. C57BL/6 male mice were used submitted to two models of emphysema induced by porcine pancreatic elastase (PPE): intratracheal (i.t.) and intranasal (i.n.). In the intratracheal model PPE was instilled at doses of 0.05 U or 0.5 U/mouse (i.t.) to temporal evaluation of emphysema 7, 14 and 21 days post-PPE instillation. Others sets of experiments, the role of iNOS was evaluated through its pharmacology inhibition by 1% aminoguanidine (AMG) into the drinking water or bt iNOS genetic exclusion in iNOS-deficient mice which had induced emphysema by 0.5 U PPE i.t. after 21 days. In the intranasal model the PPE dose was 3 U/mouse to temporal evaluation of emphysema (1, 7, 14 and 21 days after PPE). The role of oxidative and nitrosative stress was evaluated using different antioxidant treatments into the drinking water: tempol, apocynin+allopurinol, N-acetylcysteine, vitamin C+E and aminoguanidine during the 21 days of emphysema induction. Control groups were instilled with saline. Bronchoalveolar lavage, immunoassays, biochemical analysis of oxidative stress and morphometric tests were performed in the lungs of animals. The emphysema was histologically reached 21 days after 0.5 U PPE, as evidenced by an increase in alveolar diameter - Lm and volume density of the alveolar spaces - Vvair compared to the control group. TNF-a was increased in 7 and 14 days after 0.5 U PPE compared to the control, concomitant with reduction of IL-10 at the same time-points compared to the control. Oxidative stress was observed in the early stages of emphysema, with increased levels of nitrite, TBARS and superoxide dismutase in group 7 days after 0.5 U PPE (i.t.) compared to the control, while in the intranasal model the typical stress alterations were seen in group 1 day after 3 U PPE. Glutathione peroxidase activity was increased in all PPE groups (i.t.). Exposure to 0.5 U PPE ...


Subject(s)
Animals , Mice , Pulmonary Disease, Chronic Obstructive/chemically induced , Pulmonary Disease, Chronic Obstructive/metabolism , Pancreatic Elastase/administration & dosage , Pancreatic Elastase/metabolism , Pulmonary Emphysema/chemically induced , Pulmonary Emphysema/metabolism , Antioxidants/pharmacology , Oxidative Stress/physiology , Inflammation , Nitric Oxide Synthase/biosynthesis , Nitric Oxide Synthase/metabolism , Lung/pathology
3.
Rev. chil. enferm. respir ; 25(2): 77-82, 2009. ilus
Article in Spanish | LILACS | ID: lil-561838

ABSTRACT

Introduction: Intratracheal instillation of elastase induces diffuse alveolar damage and emphysema development. However, the Syrian Golden hamster develops more severe emphysema than the Sprague-Dawley rat. Although it is known that early events after elastase instillation determine the magnitude of emphysema development, it is not known if there are species differences in the initial pattern of lung response to elastase. Objective: To evaluate whether rats and hamster differ in the early lung response to elastase, using biochemical markers of acute lung injury. Results: Whereas the rat shows a large increase in alveolar-capillary permeability and few hemorrhagic changes, the hamster shows significant amount of hemorrhage and a small increase in alveolar capillary permeability. Conclusions: There are differences between rats and hamsters in the initial lung response to elastase that could influence the magnitude of emphysema development.


Introducción: El modelo de instilación intratraqueal de elastasa induce daño alveolar difuso y destrucción de la matriz extracelular con desarrollo de enfisema. Sin embargo, el hámster Syrian Golden desarrolla enfisema más severo que el de la rata Sprague-Dawley. Si bien se sabe que los eventos tempranos después de la instilación de elastasa determinan la magnitud del enfisema, se desconoce si existen diferencias entre especies en la respuesta pulmonar temprana. Objetivo: Evaluar si existen diferencias entre ratas y hamsters en la respuesta pulmonar inicial después de la elastasa, mediante el uso de marcadores bioquímicos de daño pulmonar agudo. Resultados: Mientras la rata experimenta un gran aumento de permeabilidad alvéolo-capilar y pocos fenómenos hemorrágicos, el hamster presenta abundante hemorragia y escaso aumento de la permeabilidad. Conclusiones: Existen diferencias entre ratas y hamsters en la respuesta pulmonar inicial frente a la elastasa, que podrían tener relación con las diferencias en magnitud del enfisema.


Subject(s)
Animals , Male , Rats , Pancreatic Elastase/administration & dosage , Emphysema/chemically induced , Bronchoalveolar Lavage , Disease Models, Animal , Dose-Response Relationship, Drug , Pancreatic Elastase/metabolism , Emphysema/enzymology , Hemorrhage/chemically induced , Mesocricetus , Biomarkers , Capillary Permeability , Lung , Lung/enzymology , Rats, Sprague-Dawley
4.
Experimental & Molecular Medicine ; : 614-620, 2007.
Article in English | WPRIM | ID: wpr-170425

ABSTRACT

Endothelin (ET) receptor antagonists have been developed to produce a reduction of ET related effects in various diseases, as well as in animal models of airway inflammation. We aimed to investigate the anti-inflammatory potential of bosentan on a rat model of emphysema. Thirty Wistar male rats were classified as control group (group 1), intratracheally (i.t.) instilled with saline, treated with vehicle solution; elastase group (group 2), i.t. instilled with porcine pancreatic elastase (PPE), treated with vehicle solution; and PPE+bosentan group (group 3), i.t. instilled with PPE, treated with bosentan. The levels of TNF-alpha, IL-1beta, IL-6, and IL-8 in bronchoalveolar lavage fluid (BALF) and lung tissue, cell counts in BALF, and histologic analysis of all groups were evaluated. Neutrophile granulocytes (NG) and alveolar macrophages (AM) were increased more in group 2 than in group 1 (P<0.001, P=0.04, respectively). Compared with group 2, neutrophil granulocyte (NG) and alveolar macrophages (AM) counts were decreased in group 3 (P< 0.001). Histological examination confirmed a diffuse neutrophilic inflammation and irregular alveolar air space enlargement in group 2. Treatment with bosentan partially reduced the enlarged lung volumes. Compared with group 1, the BALF levels of TNF-alpha and IL-6, and the lung tissue levels of IL-1beta, IL-6, and IL-8 were increased in group 2 (P=0.028, P=0.005, P=0.001, P=0.019, P<0.001, respectively). The TNF-alpha and IL-8 levels of BALF (P=0.007, P=0.001, respectively), and the TNF-alpha, IL-1beta, IL-6, and the IL-8 levels of lung tissue (P=0.031, P=0.017, P=0.007, P<0.001) were decreased in group 3 compared to group 2. In conclusion, bosentan decreased the inflammatory response by reducing numbers of inflammatory cells and proinflammatory cytokines.


Subject(s)
Animals , Male , Rats , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Bronchoalveolar Lavage Fluid/cytology , Cytokines/biosynthesis , Disease Models, Animal , Emphysema/drug therapy , Inflammation Mediators/metabolism , Lung/drug effects , Pancreatic Elastase/administration & dosage , Rats, Wistar , Receptors, Endothelin/antagonists & inhibitors , Sulfonamides/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL